Optimizing insulin injection technique and its effect on blood glucose control
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The purpose of the study is to assess whether proper Injection Technique (IT) is associated with improved glucose control over a three month period. Patients (N = 346) with diabetes from 18 ambulatory centers throughout northern Italy who had been injecting insulin ≥ four years answered a questionnaire about their IT. The nurse then examined the patient's injection sites for the presence of lipohypertrophy (LH), followed by an individualized training session in which sub-optimal IT practices highlighted in the questionnaire were addressed. All patients were taught to rotate sites correctly to avoid LH and were begun on 4 mm pen needles to avoid intramuscular (IM) injections. They were instructed not to reuse needles. Nearly 49% of patients were found to have LH at study entry. After three months, patients had mean reductions in HbA1c of 0.58% (0.50%–0.66%, 95% CI), in fasting blood glucose of 14 mg/dL (10.2–17.8 mg/dL, 95% CI) and in total daily insulin dose of 2.0 IU (1.4–2.5 IU, 95% CI) all with p < 0.05. Follow-up questionnaires showed significant numbers of patients recognized the importance of IT and were performing their injections more correctly. The majority found the 4 mm needle convenient and comfortable. Targeted individualized training in IT, including the switch to a 4 mm needle, is associated with improved glucose control, greater satisfaction with therapy, better and simpler injection practices and possibly lower consumption of insulin after only a three month period.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gibney, M. A., Arce, C. H., Byron, K. J., & Hirsch, L. J. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.481203 · Cited by 283
Laurent, A., Mistretta, F., Bottigioli, D., Dahel, K., Goujon, C., Nicolas, J. F., Hennino, A., & Laurent, P. E. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.05.046 · Cited by 235
Cited by
New insulin delivery recommendations
Frid, A. H., Kreugel, G., Grassi, G., Halimi, S., Hicks, D., Hirsch, L. J., Smith, M. J., Wellhoener, R., Bode, B. W., Hirsch, I. B., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.06.010 · Cited by 286
“n September 2016;91 and how to avoid them; optimal needle lengths; safe disposal of used sharps; and psychological hurdles and aids to overcome them.(137-139,143,146-149) A1”
BackgroundSelf-citationFamulla, S., Hövelmann, U., Fischer, A., Coester, H.-V., Hermanski, L., Kaltheuner, M., Kaltheuner, L., Heinemann, L., Heise, T., & Hirsch, L. (2016) · Diabetes Care · doi:10.2337/dc16-0610 · Cited by 173
Insulclock : A Novel Insulin Delivery Optimization and Tracking System
Gomez-Peralta, F., Abreu, C., Gomez-Rodriguez, S., & Ruiz, L. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0361 · Cited by 30
“12,13 Given the high burden that self-management represents for insulin users—which inversely correlates with treatment compliance—tools are needed to standardize insulin injection techniques.”
Gomez-Peralta, F., Abreu, C., Gomez-Rodriguez, S., Cruz-Bravo, M., María-Sanchez, C., Poza, G., & Ruiz-Valdepeñas, L. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0427 · Cited by 25
Dorji, T., Lhamo, P., Tshering, T., Zangmo, L., Choden, K., Choden, D., & Namgyal, K. (2018) · Asian Biomedicine · doi:10.1515/abm-2018-0028 · Cited by 4
“The needle length was a significant factor for causing pain and thus acceptability [18, 19].”
Background
Metadata
- Authors
- Grassi, G., Scuntero, P., Trepiccioni, R., Marubbi, F., & Strauss, K.
- Venue
- Journal of Clinical & Translational Endocrinology
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 1
- Issue
- 4
- Pages
- 145-150
- ISSN
- 2214-6237 (ISSN-L)
- OpenAlex
- W2155688200
- Cited by
- 116
- References
- 2
- FWCI
- 7.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.